Literature DB >> 14200790

MYASTHENIA GRAVIS WITH HYPERGAMMAGLOBULINAEMIA AND ANTIBODIES.

H J OOSTERHUIS, H VAN DER GELD, T E FELTKAMP, F PEETOOM.   

Abstract

Keywords:  ADOLESCENCE; ANTIBODY FORMATION; BLOOD PROTEIN DISORDERS; BLOOD PROTEIN ELECTROPHORESIS; GAMMA GLOBULIN; HEART NEOPLASMS; IMMUNOELECTROPHORESIS; MEDIASTINAL NEOPLASMS; MYASTHENIA GRAVIS; THYMOMA

Mesh：

Substances：

Year:  1964        PMID： 14200790      PMCID： PMC495756          DOI： 10.1136/jnnp.27.4.345

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  14 in total

1.  MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

Authors:  H VAN DER GELD; T E FELTKAMP; J VAN LOGHEM; H J OOSTERHUIS; A BIEMOND
Journal:  Lancet       Date:  1963-08-24       Impact factor: 79.321

2.  The fine structure of the myasthenic neuromuscular junction.

Authors:  S I ZACKS; W C BAUER; J M BLUMBERG
Journal:  J Neuropathol Exp Neurol       Date:  1962-07       Impact factor: 3.685

3.  Muscle and thymus antibodies in myasthenia gravis.

Authors:  H J OOSTERHUIS
Journal:  Vox Sang       Date:  1963 Mar-Apr       Impact factor: 2.144

4.  Studies on sera from cases of myasthenia gravis, using the fluorescent antibody technique.

Authors:  T E FELTKAMP; H J OOSTERHUIS
Journal:  Vox Sang       Date:  1963 May-Jun       Impact factor: 2.144

5.  Antinuclear factor in myasthenia gravis.

Authors:  T E FELTKAMP; K KRUYFF; H J OOSTERHUIS
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

6.  Studies on autoantibodies in myasthenia gravis.

Authors:  E H BEUTNER; E WITEBSKY; D RICKEN; R H ADLER
Journal:  JAMA       Date:  1962-10-06       Impact factor: 56.272

7.  Changes in serum complement activity in patients with myasthenia gravis.

Authors:  W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

8.  Myasthenic-like features of neuromuscular transmission after administration of an inhibitor of acetylcholine synthesis.

Authors:  J E DESMEDT
Journal:  Nature       Date:  1958-12-13       Impact factor: 49.962

9.  Clinicopathologic conference; refractory anemia, agammaglobulinemia, and mediastinal tumor.

Authors:  A T LAMBIE; B A BURROWS; S C SOMMERS
Journal:  Am J Clin Pathol       Date:  1957-04       Impact factor: 2.493

10.  [New determinations of protein fractions in the serum of patients with muscle disorders].

Authors:  A Lowenthal; M Van Sande
Journal:  Rev Fr Etud Clin Biol       Date:  1956-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.